home / stock / hoth / hoth news

HOTH News and Press, Hoth Therapeutics Inc. From 12/19/19

Stock Information
Company Name: Hoth Therapeutics Inc.
Stock Symbol: HOTH
Market: NASDAQ
Website: hoththerapeutics.com
Menu
HOTH HOTH Quote HOTH Short HOTH News HOTH Articles HOTH Message Board
Get HOTH Alerts

News, Short Squeeze, Breakout and More Instantly...
HOTH - Hoth Therapeutics Enters into Research Collaboration Agreement with Weill Cornell Medicine to Examine the Efficacy of RAMBA in Blocking Acne Pathogenic Gene Expression

NEW YORK , Dec. 19, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today anno...
HOTH - Hoth Therapeutics Announces the Appointment of Dr. William Weglicki, M.D. to Scientific Advisory Board

NEW YORK , Dec. 17, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today ann...

HOTH - Emerging Markets Report - Hoth Therapeutics on the Fast Track Toward Delivering Eczema Therapy Products to Market

ORLANDO, Fla., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Nearly every person suffering from atopic dermatitis, more popularly known as “eczema,” knows just how difficult it can be to find effective remedies for his or her condition. Many prescription and over-the-counter treatments ar...

HOTH - Hoth Therapeutics, Inc. to Present at the Investor Summit on December 17th in Philadelphia

PHILADELPHIA, PA / ACCESSWIRE / December 11, 2019 / Hoth Therapeutics, Inc. (NASDAQ:HOTH), will be presenting at this year's Investor Summit on December 17 th in Philadelphia. The Investor Summit will take place at Hotel Monaco, featuring 30 companies and over 200 institutional and retail ...
HOTH - Hoth Therapeutics And North Carolina State University Initiate Preclinical Gene Therapy Study For The Treatment Of Asthma

NEW YORK , Dec. 9, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, is pleased to an...

HOTH - Hoth Therapeutics to Present at the LD Micro Main Event (XII)

NEW YORK, NY / ACCESSWIRE / December 2, 2019 / Hoth Therapeutics, Inc. (NASDAQ:HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today annou...

HOTH - Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy

NEW YORK , Nov. 26, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today announced...
HOTH - Hoth Therapeutics to Attend Benchmark's 8th Annual Discovery 1x1 Conference

NEW YORK , Nov. 18, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today anno...

HOTH - Hoth Therapeutics Initiates Preclinical Study Including Topical Form of Aprepitant for Dermatological Treatment Relating to Side Effects of Cancer Medication

NEW YORK , Nov. 14, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today announced...

HOTH - Global Revenues for Atopic Dermatitis Market Expected to Grow to $18.3Billion by 2027

November 6, 2019 Palm Beach, FL – November 6, 2019 –  Atopic dermatitis is a widespread chronic inflammatory skin condition that can affect patients of all ages and is the result of a complex interplay of environmental, immunological, genetic, and pharmacologic fact...
Previous 10 Next 10